Asia Healthcare Holdings to invest Rs 400 crore in Asian Institute of Nephrology and Urology to double hospital network

Asia Healthcare Holdings will invest Rs 400 crore in Asian Institute of Nephrology and Urology. The investment will occur over the next 4-5 years. AINU plans to expand by opening 13 hospitals in Tier 2 cities. This expansion includes cities like Patna and Bhubaneshwar. The total investment will reach Rs 1,000 crore by FY30.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FypJzrY
via IFTTT

Read More

Pfizer launches next-gen vaccine for pneumococcal disease

Pfizer has introduced its 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India, offering protection against 20 serotypes responsible for a majority of pneumococcal diseases. This single-dose vaccine provides timely and proactive protection for all adults, including those with chronic conditions, potentially eliminating the need for a second dose.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/T8l6hCc
via IFTTT

Read More

Welcure Drugs & Pharma board to consider share split, bonus issue this month

Welcure Drugs & Pharmaceuticals is set to consider a stock split of 1:10 and a bonus issue of 1:1 in its upcoming board meeting on August 22. This decision follows strong financial results in Q1 FY26, with revenue from operations reaching Rs 299.91 crore and net profit surging to Rs 23.29 crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/MIrfW2R
via IFTTT

Read More

Zydus Lifesciences gets USFDA approval for angina, high blood pressure drug

Zydus Lifesciences has secured USFDA approval to market Diltiazem Hydrochloride tablets, used for treating angina and high blood pressure, in strengths of 30 mg, 60 mg, 90 mg, and 120 mg. The medication, a calcium-channel blocker, relaxes blood vessels, easing the heart's workload and improving blood flow.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4CdspvA
via IFTTT

Read More

Retinal disorders a public health crisis, need immediate prioritisation, say experts

Mission Vision, a public health initiative, has launched in India to combat the escalating crisis of vision loss due to Diabetic Retinopathy. The initiative aims to increase awareness, improve screening and treatment access, and integrate eye care into routine diabetes management.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/UecTf9s
via IFTTT

Read More

Managing diabetes in a country obsessed with quick fixes: A scientific perspective

Diabetes management faces challenges due to patients' preference for quick fixes over sustainable lifestyle changes. These shortcuts, like extra medication or unproven supplements, offer temporary relief but neglect long-term disease control. Shifting mindsets requires holistic approaches, personalized support, and collaborative healthcare to promote lasting healthy habits and prevent complications.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wmz1MyF
via IFTTT

Read More

Govt gives BIS exemption to parts used in medical devices for now

The steel ministry has temporarily suspended its notification requiring Indian standards compliance for raw materials used in medical device manufacturing, offering relief to the industry. They will issue no-objection certificates for importing special stainless steel grades and allow foreign suppliers six months to obtain Bureau of Indian Standards registration.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xAzXsHv
via IFTTT

Read More